Private Advisor Group, LLC Cellectar Biosciences, Inc. Transaction History

Private Advisor Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$10.6 - $16.6 $5,300 - $8,300	-500 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$10.3 - $17.3 $5,150 - $8,650	500 New	500 $1,000
Q4 2019 Feb 10, 2020	SELL	$10.6 - $24.1 $142,040 - $322,940	-13,400 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.6 - $28.2 $249,240 - $377,880	13,400 New	13,400 $0

Ticker CLRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,114,290
Market Cap $9.6M
Description
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.